August 12, 2025 | 12:00am

MANILA, Philippines — Ayala Healthcare Holdings Inc. (AC Health), the Ayala Group’s health care arm, has sealed the sale of a minority stake in the company to a Singapore-based impact investor backed by Temasek Trust and Temasek.

In a stock exchange filing, Ayala Corp. said IMP2 Rise Pte. Ltd., a special purpose vehicle of ABC Impact Fund II LP, would infuse primary capital for a 16-percent minority stake in AC Health.

The fresh capital will fuel AC Health’s expansion across its core pillars of hospitals, multi-specialty clinics and retail pharmacies through a combination of organic initiatives and targeted acquisitions.

AC Health intends to expand its network to at least 10 hospitals, 300 clinics and 1,150 pharmacies by 2027.

Aside from aggressively expanding its network in the next three years, AC Health also aims to become a $2-billion health care company by 2035.

“This partnership marks a significant milestone in AC Health’s journey. ABC Impact’s investment reinforces the strength of our integrated model and our commitment to making health care more inclusive,” AC Health president and CEO Paolo Borromeo said.

“This partnership creates valuable opportunities for knowledge exchange, technology transfer and the adoption of global best practices, further enabling AC Health to raise the bar in care quality, patient safety and operational efficiency as it moves toward world-class standards,” Borromeo said.

ABC Impact’s strategic investment marks its entry into the Philippine health care sector, expanding its regional footprint.

As an impact investor dedicated to Asia with existing health care investments in India, China and Vietnam, ABC Impact is bringing in regional insights and networks to support AC Health in tapping into clinical excellence and health care innovation across the region.

ABC Impact likewise sees opportunities for knowledge-sharing and future collabor...